Consensus $7.42. Raises FY23 revenue view to $2.97B-$2.99B from $2.94B-$2.96B, consensus $2.96B. Sees FY23 capital spending $350M.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on WST:
- West Announces First-Quarter 2023 Results and Declares Third-Quarter 2023 Dividend
- WST Upcoming Earnings Report: What to Expect?
- Stephens upgrades West Pharmaceutical amid ‘fear of missing out’
- West Pharmaceutical upgraded to Overweight from Equal Weight at Stephens
- West Announces Second-Quarter 2023 Dividend